CRISPR Therapeutics' market value is the price at which a share of CRISPR Therapeutics trades on a public exchange. It measures the collective expectations of CRISPR Therapeutics AG investors about its performance. CRISPR Therapeutics is trading at 31.52 as of the 4th of January 2025, a 6.38 percent increase since the beginning of the trading day. The stock's open price was 29.63. With this module, you can estimate the performance of a buy and hold strategy of CRISPR Therapeutics AG and determine expected loss or profit from investing in CRISPR Therapeutics over a given investment horizon. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
Symbol
CRISPR
CRISPR Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to CRISPR Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of CRISPR Therapeutics.
0.00
12/05/2024
No Change 0.00
0.0
In 31 days
01/04/2025
0.00
If you would invest 0.00 in CRISPR Therapeutics on December 5, 2024 and sell it all today you would earn a total of 0.00 from holding CRISPR Therapeutics AG or generate 0.0% return on investment in CRISPR Therapeutics over 30 days.
CRISPR Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure CRISPR Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess CRISPR Therapeutics AG upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for CRISPR Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as CRISPR Therapeutics' standard deviation. In reality, there are many statistical measures that can use CRISPR Therapeutics historical prices to predict the future CRISPR Therapeutics' volatility.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as CRISPR Therapeutics. Your research has to be compared to or analyzed against CRISPR Therapeutics' peers to derive any actionable benefits. When done correctly, CRISPR Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in CRISPR Therapeutics.
CRISPR Therapeutics Backtested Returns
At this point, CRISPR Therapeutics is not too volatile. CRISPR Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0245, which signifies that the company had a 0.0245% return per unit of return volatility over the last 3 months. We have found twenty-seven technical indicators for CRISPR Therapeutics AG, which you can use to evaluate the volatility of the firm. Please confirm CRISPR Therapeutics' Risk Adjusted Performance of 0.0132, semi deviation of 2.34, and Mean Deviation of 1.37 to double-check if the risk estimate we provide is consistent with the expected return of 0.0736%. CRISPR Therapeutics has a performance score of 1 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.2, which signifies not very significant fluctuations relative to the market. As returns on the market increase, CRISPR Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding CRISPR Therapeutics is expected to be smaller as well. CRISPR Therapeutics now shows a risk of 3.01%. Please confirm CRISPR Therapeutics downside deviation, information ratio, total risk alpha, as well as the relationship between the coefficient of variation and jensen alpha , to decide if CRISPR Therapeutics will be following its price patterns.
Auto-correlation
-0.35
Poor reverse predictability
CRISPR Therapeutics AG has poor reverse predictability. Overlapping area represents the amount of predictability between CRISPR Therapeutics time series from 5th of December 2024 to 20th of December 2024 and 20th of December 2024 to 4th of January 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of CRISPR Therapeutics price movement. The serial correlation of -0.35 indicates that nearly 35.0% of current CRISPR Therapeutics price fluctuation can be explain by its past prices.
Correlation Coefficient
-0.35
Spearman Rank Test
-0.29
Residual Average
0.0
Price Variance
0.47
CRISPR Therapeutics lagged returns against current returns
Autocorrelation, which is CRISPR Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting CRISPR Therapeutics' stock expected returns. We can calculate the autocorrelation of CRISPR Therapeutics returns to help us make a trade decision. For example, suppose you find that CRISPR Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values
Timeline
CRISPR Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If CRISPR Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if CRISPR Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in CRISPR Therapeutics stock over time.
Current vs Lagged Prices
Timeline
CRISPR Therapeutics Lagged Returns
When evaluating CRISPR Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of CRISPR Therapeutics stock have on its future price. CRISPR Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, CRISPR Therapeutics autocorrelation shows the relationship between CRISPR Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in CRISPR Therapeutics AG.
Regressed Prices
Timeline
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.